131 related articles for article (PubMed ID: 26247683)
1. EAS Consensus Panel statement on homozygous FH.
Stock J
Atherosclerosis; 2015 Sep; 242(1):323-6. PubMed ID: 26247683
[No Abstract] [Full Text] [Related]
2. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility gene card for: hyperlipoproteinemia, TYPE II.
Kassner U; Wühle-Demuth M; Missala I; Humphries SE; Steinhagen-Thiessen E; Demuth I
Eur J Hum Genet; 2014 Jul; 22(7):. PubMed ID: 24253857
[No Abstract] [Full Text] [Related]
4. [Molecular basis of familial hypercholesterolemia-like phenotype heterogeneity].
Wang LY; Lin J; Liu S; Chen BS
Yi Chuan Xue Bao; 2005 Jul; 32(7):770-7. PubMed ID: 16078748
[TBL] [Abstract][Full Text] [Related]
5. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
Tada H; Kawashiri MA; Ohtani R; Noguchi T; Nakanishi C; Konno T; Hayashi K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
Atherosclerosis; 2011 Dec; 219(2):663-6. PubMed ID: 21872251
[TBL] [Abstract][Full Text] [Related]
6. Landmark position paper on paediatric familial hypercholesterolaemia from the EAS Consensus Panel.
Stock J
Atherosclerosis; 2015 Sep; 242(1):277-80. PubMed ID: 26232168
[No Abstract] [Full Text] [Related]
7. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of familial hypercholesterolaemia.
Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM
Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791
[TBL] [Abstract][Full Text] [Related]
9. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes.
Damgaard D; Jensen JM; Larsen ML; Soerensen VR; Jensen HK; Gregersen N; Jensen LG; Faergeman O
Atherosclerosis; 2004 Dec; 177(2):415-22. PubMed ID: 15530918
[TBL] [Abstract][Full Text] [Related]
10. Molecular-genetic aspects of familial hypercholesterolemia.
Gabcova-Balaziova D; Stanikova D; Vohnout B; Huckova M; Stanik J; Klimes I; Raslova K; Gasperikova D
Endocr Regul; 2015 Jul; 49(3):164-81. PubMed ID: 26238499
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of familial hypercholesterolaemia in Western Australia.
Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of familial hypercholesterolemia in Spain.
Palacios L; Grandoso L; Cuevas N; Olano-Martín E; Martinez A; Tejedor D; Stef M
Atherosclerosis; 2012 Mar; 221(1):137-42. PubMed ID: 22244043
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis.
Di Taranto MD; D'Agostino MN; Fortunato G
Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249
[TBL] [Abstract][Full Text] [Related]
14. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
[TBL] [Abstract][Full Text] [Related]
15. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.
Sjouke B; Kusters DM; Kindt I; Besseling J; Defesche JC; Sijbrands EJ; Roeters van Lennep JE; Stalenhoef AF; Wiegman A; de Graaf J; Fouchier SW; Kastelein JJ; Hovingh GK
Eur Heart J; 2015 Mar; 36(9):560-5. PubMed ID: 24585268
[TBL] [Abstract][Full Text] [Related]
16. Genetics of familial hypercholesterolemia.
Brautbar A; Leary E; Rasmussen K; Wilson DP; Steiner RD; Virani S
Curr Atheroscler Rep; 2015 Apr; 17(4):491. PubMed ID: 25712136
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the first PCSK9 gain of function homozygote.
Alves AC; Etxebarria A; Medeiros AM; Benito-Vicente A; Thedrez A; Passard M; Croyal M; Martin C; Lambert G; Bourbon M
J Am Coll Cardiol; 2015 Nov; 66(19):2152-2154. PubMed ID: 26541928
[No Abstract] [Full Text] [Related]
19. Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy.
Romano M; Di Taranto MD; D'Agostino MN; Marotta G; Gentile M; Abate G; Mirabelli P; Di Noto R; Del Vecchio L; Rubba P; Fortunato G
Atherosclerosis; 2010 Jun; 210(2):493-6. PubMed ID: 20045108
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.
Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Tada H; Nakanishi C; Mori M; Yamagishi M; Inazu A; Koizumi J;
Atherosclerosis; 2011 Feb; 214(2):404-7. PubMed ID: 21146822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
